The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms, and the gravity of unmet needs, as well as the growing importance of technologies such as pharmacogenomics, digital therapeutics, and artificial intelligence. In the last three years alone, there have been over 787,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Microbiome in pharma: bacteriophage therapyBuy the report here.

Smarter leaders trust GlobalData


Premium Insights Microbiome in pharma: bacteriophage therapy

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s Technology Foresights, which uses over 668,000 patents to analyze innovation intensity for the pharmaceutical industry, there are 80+ innovation areas that will shape the future of the industry.

Bacteriophage therapy is a key innovation area in microbiome

Bacteriophage therapy, also known as phage therapy, is a type of treatment that uses naturally occurring viruses called bacteriophages to target and kill harmful bacteria in the body. Bacteriophages are specific to the type of bacteria they target, making them a potential alternative to antibiotics and a promising option for treating bacterial infections.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.  According to GlobalData, there are 20+ companies, spanning technology vendors, established pharmaceutical companies, and up-and-coming start-ups engaged in the development and application of bacteriophage therapy.

Key players in bacteriophage therapy – a disruptive innovation in the pharmaceutical industry

‘Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.   

‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.  

Patent volumes related to bacteriophage therapy

Company Total patents (2010 - 2022) Premium intelligence on the world's largest companies
iNtRON Biotechnology 177 Unlock Company Profile
Snipr Technologies 53 Unlock Company Profile
CJ 46 Unlock Company Profile
Phico Therapeutics 34 Unlock Company Profile
Pherecydes Pharma 23 Unlock Company Profile
Industria Tecnica Farmaceutica 23 Unlock Company Profile
Armata Pharmaceuticals 21 Unlock Company Profile
Laboratory Corp of America 17 Unlock Company Profile
Eligo Bioscience 16 Unlock Company Profile
GSK 14 Unlock Company Profile
TechnoPhage 13 Unlock Company Profile
Micreos 11 Unlock Company Profile
Locus Biosciences 10 Unlock Company Profile
SNIPR Biome 8 Unlock Company Profile
Pastoral Greenhouse Gas Research 7 Unlock Company Profile
Nestle 6 Unlock Company Profile
GangaGen 4 Unlock Company Profile
Royal DSM 3 Unlock Company Profile
Can Technologies 2 Unlock Company Profile
Pastoral Greenhouse Research 2 Unlock Company Profile
PHI Therapeutics 1 Unlock Company Profile
Intralytix 1 Unlock Company Profile
Teagasc 1 Unlock Company Profile
Inst Animal Science & Veterinary Medicine Shandong 1 Unlock Company Profile

Source: GlobalData Patent Analytics

Intron Biotechnology (Intron Bio) is one of the leading patent filers in bacteriophage therapy. The drug development company focuses on biotechnology and genetic engineering, which can be used to treat human diseases. Its technologies include endolysin, bacteriophage, and biofilm. The company's endolysin technology is an antibiotic substance that destroys the cell walls of bacteria. The company also develops infectious disease drugs. Snipr Biome and CJ are some of the other key patent filers in bacteriophage therapy.

In terms of application diversity, Intralytix leads the pack, while iNtRON Biotechnology and Micreos stood in the second and third positions, respectively. By means of geographic reach, Phico Therapeutics held the top position, followed by Industria Tecnica Farmaceutica and GSK.

To further understand the key themes and technologies disrupting the pharmaceutical industry, access GlobalData’s latest thematic research report on Microbiome.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.